# Aliada Therapeutics, Inc. — Form D

Aliada Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-07. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-07-07
- Form: D
- Accession: 0001870878-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 2
- Date of first sale: 2021-06-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-405380

## Issuer

- Name: Aliada Therapeutics, Inc.
- CIK: 0001870878
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 200 BERKELEY STREET, 23rd FLOOR, BOSTON, MA, 02116
- Phone: 617-721-0860

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Marian J Nakada | Director | Boston, MA |
| Sari Epstein | Executive Officer | Boston, MA |
| Laura J Tadvalkar | Director | Boston, MA |
| Adam J Rosenberg | Director | Boston, MA |
| Adam J Rosenberg | Executive Officer | Boston, MA |
| Jim J Sullivan | Director | Boston, MA |
| Joshua J Resnick | Director | Boston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-12-30](https://search.stillhousedata.com/formd/0001870878-22-000001) | D | $32.0M | $32.0M |

## More

- [CIK 1870878 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1870878&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001870878-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.